Covered recipient · General Payments record
KEITH A MEYER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$182.65
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.22 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $37.41 | 2 |
| Mylan Specialty L.P. | $32.44 | 2 |
| Exact Sciences Corporation | $20.52 | 1 |
| PFIZER INC. | $18.47 | 1 |
| Acerta Pharma LLC | $15.64 | 1 |
| Merck Sharp & Dohme Corporation | $14.59 | 1 |
| Lundbeck LLC | $14.32 | 1 |
| ITI, Inc. | $13.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.64 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104542772 | CMS |
| Exact Sciences Corporation | $20.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114787317 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13.83 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143278144 | CMS |
| Lundbeck LLC | $14.32 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145946130 | CMS |
| Merck Sharp & Dohme LLC | $14.59 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141822915 | CMS |
| Mylan Specialty L.P. | $16.22 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147326456 | CMS |
| Mylan Specialty L.P. | $16.22 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147287870 | CMS |
| Novo Nordisk Inc | $16.58 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096857544 | CMS |
| Novo Nordisk Inc | $20.83 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096881997 | CMS |
| PFIZER INC. | $18.47 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131695816 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.